Get alerts on new MANKIND PHARMA LIMITED bonds
Top yield
8.15%
latest traded
Trading now
2
of 2 live
Instruments
2
outstanding
Top rating
AA+
at issue
Traded yield by time to maturity
Each point is a different security, so the line is a shape, not an apples-to-apples curve. Yields are not directly comparable: seniority, security cover and collateral, put and call options, step-ups and covenants all differ line to line. Read each security on its own terms.
| The credit grade assigned at issuance (per rating agency). It is not a live or current rating; subsequent surveillance changes aren't reflected here, so always check the issuer's latest credit rating for an updated view before you invest. | ||||
|---|---|---|---|---|
Mankind PharmaINE634S07033NCD | AA+ | 7.97% | 16 Nov 20271.4y left | 8.15% |
Mankind PharmaINE634S07025NCD | AA+ | 7.99% | 16 Oct 20264mo left | 7.45% |
Secured: backed by a charge over the issuer's assets. Unmarked lines are unsecured.
Click any security to compare it across platforms against the live exchange-traded yield. A blank yield means no recent trade, not no value.
Capera
Neutrality
Guarantee
Neutrality guarantee
Prices you can't pay to move.
Capera is editorially independent. We may earn from the platforms and institutions we list, but a commercial arrangement never changes the price or yield we show you.